Despite our omnivory, a census of the glycoside hydrolases (GH) encoded by the human genome indicates that our inherent ability to digest carbohydrates is restricted to starch and simple saccharides, e.g. malto-oligosaccharides, sucrose and lactose.^[@R2]^ Consequently, the human gut microbiota and its cohort of predicted carbohydrate-active enzymes are implicated in the conversion of otherwise indigestible plant polysaccharides to short-chain fatty acids,^[@R2],[@R7],[@R13]^ which provides up to 10% of the daily caloric intake in humans^[@R14],[@R15]^ and is central to colonic heath.^[@R4],[@R9],[@R11],[@R16]^ Despite an increasing body of (meta)genomic sequence data,^[@R13],[@R17]--[@R20]^ the enzymatic pathways by which the most common dietary polysaccharides are digested in the human gut have not been elucidated.^[@R7],[@R13]^

XyGs are widespread in the vegetables we consume: Dicot primary cell walls, for example those of lettuce, onions and tomatoes, may contain up to 25% XyG on a dry-weight basis.^[@R1],[@R5],[@R6]^ The primary walls of commelinoid monocots, including the cereals, contain much lower (1--5%) -- but still non-zero -- amounts of XyGs.^[@R1],[@R6]^ Seed XyGs are also widely used as food thickening agents and have been employed as drug delivery matrices in the intestine.^[@R21]^ This family of polysaccharides is typified by a β(1→4)-glucan main chain that is heavily substituted with pendant α(1→6)-linked xylosyl units. Depending on the species and tissue of origin, these branches may be further extended by additional monosaccharides, including galactose, fucose, and/or arabinose ([Figure 1](#F1){ref-type="fig"}).^[@R5],[@R22]^ As such, complete saccharification in the gut necessarily requires a cadre of enzymes to address the monosaccharide and linkage diversity of these complex polysaccharides.

We recently identified a polysaccharide utilization locus (PUL) in the genome of a common human gut symbiont *B. ovatus*, but not in the closely related model species *B. thetaiotaomicron*,^[@R17]^ that was transcriptionally up-regulated in response to growth on galactoxyloglucan.^[@R7]^ By homology with the archetypal starch utilization system (Sus) of *B. thetaiotaomicron*, this PUL was predicted to encode an outer membrane sugar-binding protein (SusD-like), a TonB-dependent sugar receptor/transporter (SusC-like), and an inner membrane hybrid two-component sensor. Further analysis strikingly revealed that this PUL was also predicted to encode eight glycoside hydrolases (GHs) from six enzyme families ([Figure 2](#F2){ref-type="fig"}), which tantalizingly suggested a collective role in XyG utilization by *B. ovatus*. To establish a direct causal link for growth on XyG^[@R7],[@R8]^ and outline a pathway for its degradation, we performed an in-depth molecular characterization of the PUL through reverse genetics, *in vitro* protein biochemistry and enzymology, and structural biology.

A mutant strain of *B. ovatus* harbouring a targeted deletion of the complete predicted xyloglucan utilization locus (XyGUL, [Figure 2](#F2){ref-type="fig"}) was indeed completely unable to grow on tamarind XyG as the sole carbon source, but was otherwise phenotypically identical to the wild-type strain (data not shown). This indicated an absolute requirement for one or more of the corresponding gene products in XyG catabolism. Subsequently, all eight predicted GHs were produced recombinantly in *E. coli* and subjected to detailed enzymatic characterization to establish their substrate specificities and reaction products ([Extended Data Table ED1](#T1){ref-type="table"}, [Supplementary Figures S1--20](#SD1){ref-type="supplementary-material"}). All enzymes were maximally active in the pH range 6.0--7.0, which is consistent with function in the distal human gut ([Supplementary Figures S1--6](#SD1){ref-type="supplementary-material"}).

Reducing-sugar assays and mass spectrometry (MS) demonstrated that the recombinant *Bo*GH5A and *Bo*GH9A enzymes were versatile *endo*-xyloglucanases, which cleaved the backbone of the three major types of natural xyloglucans, i.e. seed galactoxyloglucan from tamarind kernel, dicot fucogalactoxyloglucan from lettuce leaves, and solanaceous arabinogalactoxyloglucan from tomato fruit, to produce xyloglucan oligosaccharides (XyGOs) based on a Glc~4~ backbone ([Extended Data Table ED1](#T1){ref-type="table"} and [Supplementary Figures S7--10](#SD1){ref-type="supplementary-material"}, *cf.* [Figure 1](#F1){ref-type="fig"}). Assays on chromogenic aryl β-glycosides of XyGOs and natural XyGOs, together with product analyses, revealed the following *exo*-specificities for the remaining XyGUL enzymes: *Bo*GH2A, β-galactosidase; *Bo*GH3A and *Bo*GH3B, β-glucosidase; *Bo*GH31A α-xylosidase; *Bo*GH43A and *Bo*GH43B, α-L-arabinofuranosidase ([Extended Data Table ED1](#T1){ref-type="table"}, [Supplementary Data Figures S11--20](#SD1){ref-type="supplementary-material"}). This profile of activities, together with phenotypic data from additional gene-specific knock-out strains ([Extended Data Table ED2](#T2){ref-type="table"}), allowed us to outline a complete model of XyG degradation by *B. ovatus* ([Figure 3](#F3){ref-type="fig"}).

Analogous to the *endo*-amylase SusG of the *B. thetaiotaomicron* starch utilization system,^[@R4]^ the vanguard role in XyG utilization by *B. ovatus* is performed by the versatile *endo*-xyloglucanase *Bo*GH5A, which generates short XyGOs for uptake ([Figure 3](#F3){ref-type="fig"}). Indeed, a gene-specific knock-out of *Bo*GH5A rendered *B. ovatus* incapable of growth on XyG polysaccharide, but this phenotype could be directly rescued by the addition of XyGOs produced exogenously by recombinant *Bo*GH5A ([Extended Data Table ED2](#T2){ref-type="table"}, *cf.* [Supplementary Figure S8](#SD1){ref-type="supplementary-material"}). In contrast, a gene-specific knock-out of *Bo*GH9A had no effect on growth ([Extended Data Table ED2](#T2){ref-type="table"}), consistent with the observation that although this enzyme produced the same limit digestion products from all XyGs as *Bo*GH5, *Bo*GH9A was catalytically feeble with kinetics too slow to be quantified ([Extended Data Table ED1](#T1){ref-type="table"}, [Supplementary Figure S8--10](#SD1){ref-type="supplementary-material"}). That a corresponding GH9 member is not found in orthologous XyGULs from other species, nor in a *B. ovatus* strain possessing a simpler XyGUL, which were all capable of growth on tamarind XyG ([Figure 2](#F2){ref-type="fig"}, [Extended Data Figures ED1](#F6){ref-type="fig"} & [ED2](#F7){ref-type="fig"}), suggests *Bo*GH9A may be largely superfluous, or plays a specialised role not revealed in our analysis.

A gene-specific knock-out of the α-xylosidase *Bo*GH31A severely reduced *B. ovatus* growth on tamarind XyG and completely abolished growth on XyGOs ([Extended Data Table ED2](#T2){ref-type="table"}). This is consistent with an essential role in removal of α(1→6)-xylosyl residues from the non-reducing-end of XyGOs (converting "X" units to "G"), to allow subsequent hydrolysis by the β-glucosidases *Bo*GH3A and *Bo*GH3B (removing backbone "G" units), and the β-galactosidase *Bo*GH2A (or another β-galactosidase converting "L"→"X", [Figure 3](#F3){ref-type="fig"}). The two α-L-arabinofuranosidases, *Bo*GH43A and *Bo*GH43B, encoded by the XyGUL provide additional capacity to convert "S"→"X", thereby enabling complete hydrolysis of solanaceous (e.g., tomato, eggplant, pepper, etc.) arabinogalactoxyloglucan. It is presently unclear if the doubling of GH3- and GH43-encoding genes in the XyGUL has any biological importance; the similar specific activities of *Bo*GH3A and *Bo*GH3B toward XyGO β-glucosides suggests functional redundancy, while the apparent catalytic feebleness of *Bo*GH43B toward arabinofuranosides ([Extended Data Table ED1](#T1){ref-type="table"}) may suggest simple loss-of-function or evolution of a currently unresolved, orthogonal activity contrasting that of *Bo*GH43A. Notably, the *B. ovatus* XyGUL does not encode an α-fucosidase, as might be anticipated for the cleavage of the "F" sidechain in dicot fucogalactoxyloglucan ([Figure 1](#F1){ref-type="fig"}). This may reflect compensation by exogenous or endogenous α(1→2)-fucosidases^[@R2]^ or strain specialisation for XyGs from individual plant sources. Indeed, XyGULs from other *Bacteroides* species encode predicted α-fucosidases from families GH29 and GH95 ([Figure 2](#F2){ref-type="fig"}).

To provide further insight into XyG recognition by the keystone enzyme, we solved the three-dimensional structure of *Bo*GH5A in complex with the heptasaccharide XXXG by X-ray crystallography ([Figure 4](#F4){ref-type="fig"}, [Extended Data Table ED3](#T3){ref-type="table"}). The tertiary structure comprised a 96 residue "Bacteroidetes-Associated Carbohydrate-binding Often N-terminal (BACON)" domain^[@R23]^ followed by a 372 residue C-terminal GH5 domain. The BACON domain composed an 8-stranded, immunoglobulin-like β-sandwich fold and represents, to our knowledge, the first 3-D representative of this domain family. Notably, the two molecules in the asymmetric unit displayed a large difference in the relative orientations of the BACON and GH5 domains ([Figure 4A](#F4){ref-type="fig"}). This suggested significant flexibility in the enzyme ([Supplementary Video V1](#SD4){ref-type="supplementary-material"}), which is anchored on the cell surface via N-terminal lipidation; mutation of the predicted lipidation site (Cys1-\>Ala) ablates surface localization and hampers growth on XyG ([Extended Data Figure ED3](#F8){ref-type="fig"}). Notably, we were unable to find experimental evidence *in vitro* that the BACON domain functions in substrate binding ([Extended Data Figure ED4](#F9){ref-type="fig"}), nor that it mediates interactions with other proteins of the XyGUL (native PAGE data not shown). In contrast, the observation of strong XyG binding ([Extended Data Figure ED4](#F9){ref-type="fig"}) by the SusD-like protein and neighboring gene product ([Figure 2](#F2){ref-type="fig"}, loci Bacova_02651 and Bacova_02650, respectively) indicates that, as in the archetypal Sus system,^[@R24]^ polysaccharide binding is mediated by independently encoded, non-catalytic proteins of the XyGUL. Thus, the broad designation of BACON domains as "carbohydrate-binding", as inferred by bioinformatics alone, may be actively misleading.^[@R23],[@R25]^ In light of current experimental data, the most parsimonious conclusion is that the primary function of the BACON domain in *Bo*GH5A may be to distance the catalytic module from the cell surface and confer additional mobility to the catalytic domain for attack of the polysaccharide.

The catalytic domain has the prototypical (α/β)~8~ fold typical of other GH5 members and is most similar to *Paenibacillus pabuli endo*-xyloglucanase *Pp*XG5 (PDB ID 2jep; r.m.s.d. 1.47 Å, 330 Cα atoms) and *Clostridium cellulovorans endo*-glucanase EngD (PDB ID 3icg; r.m.s.d. 1.45 Å, 345 Cα atoms) of subfamily 4 (ref. ^[@R26]^). The heptasaccharide XXXG was observed to extend from subsites -4 to -1 in the active site cleft in both molecules of the asymmetric unit, with binding mediated via sugar-aromatic ring interactions and hydrogen bonds to both backbone and branching substrate moieties ([Figure 4B](#F4){ref-type="fig"}, [Supplementary Video V2](#SD5){ref-type="supplementary-material"}). The structure of this complex is well-correlated with activity on chromogenic XyGO aryl β-glycoside substrates, which indicated that the enzyme productively harnesses the Xylα(1→6) sidechains for catalysis ([Extended Data Table ED1](#T1){ref-type="table"}). Detailed comparison with the *Pp*XG5:GXLG structure (PDB ID 2jeq)^[@R27]^ revealed that binding of the β(1→4)-glucan backbone is essentially identical in the two enzymes, while differences emerge in the subsites that accommodate the branching sugar residues ([Supplementary Video V2](#SD5){ref-type="supplementary-material"}). Regardless, it is clear that a broad active site cleft engendering binding plasticity is the key feature allowing *Bo*GH5A to accommodate a wide range of natural xyloglucans.

With a solid molecular understanding of the locus that confers *B. ovatus* with the ability to utilize XyG, we undertook a growth analysis of 292 individual Bacteroidetes strains isolated from the human gut, representing 29 different named species, to reveal the distribution of this trait in nature. XyG catabolism was rare, confined to 70 strains belonging to just 6 individual, phylogenetically dispersed species ([Figure 5](#F5){ref-type="fig"}). Of the 25 *B. ovatus* strains tested, all but one grew on tamarind XyG. Interestingly, none of the 18 strains of the closely related *B. xylanisolvens* exhibited growth on XyG, which suggested that the XyGUL has been independently acquired by the *B. ovatus* lineage. This is supported by a comparative genomic analysis of the XyGUL and surrounding chromosomal region in these two species ([Extended Data Figure ED1](#F6){ref-type="fig"}). All ten strains tested of the more distantly related *B. cellulosyliticus* grew very well on XyG, comparable to the less proficient *B. ovatus* strains. Representing a third phylogenetic clade, the single *B. fluxus* strain also grew to high density on XyG. Of 37 strains of *B. uniformis*, which is closely related to *B. fluxus* and among the most abundant organisms in the microbiota of Westerners,^[@R18]^ 33 exhibited varying capacity to grow on XyG. Finally, two non-*Bacteroides* species, *Dysgonomonas gadei* and *D. mossii*, which are rarely observed in humans, but are abundant in termites, also possessed the ability to degrade xyloglucan, revealing that this phenotype has evolved in other lineages of Bacteroidetes.

A comparative analysis using genomic sequence data available for many of the strains tested showed a perfect concordance of the presence of an orthologous XyGUL and the ability to utilize XyG. Thus, we revealed putative XyGULs in *B. cellulosyliticus, B. uniformis*, *B. fluxus, D. mossii* and *D. gadei*, as well as in two sequenced species, *B. coprocola* and *B. salanitronis*, that were not available to directly test growth ([Figures 2](#F2){ref-type="fig"} & [5](#F5){ref-type="fig"}). These XyGULs were all activated during growth on XyG ([Extended Data Figure ED2](#F7){ref-type="fig"}) and shared a similar overall organisation with that of *B. ovatus*, but did not share similar flanking regions in their genomes, suggesting that they were acquired via separate events. In notable contrast to a recent report showing that conjugative transposons are capable of mediating horizontal transfer of new PULs into *Bacteroides* genomes,^[@R28]^ there is no evidence of such a mechanism for XyGUL acquisition. Rather, the XyGUL appears to have been precisely inserted between two ancestral genes that are shared by all sequenced strains. For example, on the left side of XyGUL ([Figure 2](#F2){ref-type="fig"}, [Extended Data Figure ED1](#F6){ref-type="fig"}), there are only 108 bp between the 3′ end of *BoGH3A* (Bacova_02644) and the end of the adjacent shared region; on the right side there are only 640 bp between the end of *BoGH3B* (Bacova_02659) and the second adjacent shared region.

To underscore the broad importance of dietary xyloglucan metabolism, we surveyed public metagenomic data from 250 adult humans revealing that 92% harbor at least one of five different *Bacteroides* XyGULs identified in this study ([Extended Data Figure ED5](#F10){ref-type="fig"}). In contrast, the presence of a PUL involved in degrading the red algal polysaccharide porphyran (a component of the food product *nori*)^[@R29]^ was exceptionally rare in the same population, and largely confined to a small cohort of Japanese subjects. To demonstrate that a metabolic advantage is associated with possessing a XyGUL, a competition experiment was performed using germfree mice co-colonized with wild-type *B. ovatus* and an isogenic XyGUL deletion mutant. Both strains competed equally when glucose was presented as the sole dietary carbohydrate or when XyG was presented in a mixture of polysaccharides from natural vegetable sources (a diet comprising equal amounts of cooked bell pepper, eggplant, tomato fruit and lettuce). However, when this complex diet was removed and XyG was maintained as the only exogenous polysaccharide via the drinking water, the *B. ovatus* XyGUL mutant exhibited a significant fitness defect over a three-week period ([Extended Data Figure ED6](#F11){ref-type="fig"}).

The prevalence of XyGs in the human diet suggests that the mechanism by which bacteria degrade these complex polysaccharides is highly important to human energy acquisition. Moreover, the rarity of XyG metabolism ([Figure 5](#F5){ref-type="fig"}, see also ref. ^[@R8]^) highlights the significance of *B. ovatus* and other proficient XyG-degrading Bacteroidetes as key members of the human gut microbial consortium.^[@R10]^ Additional work will now be required to determine if bacteria from other groups have evolved strategies to attack this ubiquitous plant cell wall polysaccharide in competition or synergy with members of the Bacteroidetes.^[@R8],[@R30]^ An unexpected finding is the specific adaptation of the glycoside hydrolase complement of some XyGULs to XyGs from different plant sources; this theme that may extend to other groups of plant polysaccharides and host mucosal glycans with similar or greater degrees of fine-structural variation. Following the example presented here, defining cohorts of enzymes and binding proteins that coordinate to target other complex dietary polysaccharides will be essential to fully elucidate the systems biology of gut microbial catabolism. Such refined mechanistic understanding will be essential in designing rational intervention strategies, including prebiotics, probiotics or microbial community transplants, which aim to manipulate the membership, function and stability of this important ecosystem.^[@R4],[@R9]--[@R12]^

Methods {#S2}
=======

Growth analysis of *Bacteroides* species & reverse genetics {#S3}
-----------------------------------------------------------

The locus tags of the genes involved in the present study and the corresponding DNA primers used for knock-out, sequence alteration and qPCR studies are given in [Supplementary Table S1](#SD1){ref-type="supplementary-material"}. To construct gene deletions in *B. ovatus* strain ATCC 8483, a deletion of the gene encoding thymidine kinase (*tdk*; Bacova_03071) was first constructed using an identical strategy to that used previously for *B. thetaiotaomicron*.^[@R31]^ All subsequent gene deletions and sequence modifications were conducted in a Δ*tdk* strain background by allelic exchange using the vector **pExchange-*tdk***^[@R31]^ and primers listed in [Supplementary Table S1](#SD1){ref-type="supplementary-material"}. Wild-type *Bacteroides ovatus* ATCC 8483, all mutant derivatives and other Bacteroidetes species tested were grown in tryptone-yeast extract-glucose (TYG) medium, brain-heart infusion agar supplemented with 10% horse blood, or minimal media (MM) supplemented with appropriate carbohydrates as previously described.^[@R32]^ Antibiotics were added as needed: gentamicin (200 μg ml^−1^), erythromycin (25 μg ml^−1^), and 5-fluoro-2′-deoxyuridine (200 μg ml^−1^). To prepare cells for exposure to glycans, wild-type and mutant *B. ovatus* were grown in TYG, subcultured into MM-glucose, grown to mid-exponential phase (OD~600~ 0.6--0.8), then washed and resuspended in 2x MM prior to addition of the appropriate glycan. Xyloglucan substrates are described below and all carbohydrate stocks were prepared at 10 mg/ml in ddH~2~O and sterilized by autoclaving. All quantitative growth was performed at 37°C in an anaerobic chamber (Coy Manufacturing, Grass Lake, MI; 10 % H~2~, 5 % CO~2~ and 85 % N~2~) in an automated plate reading device as described previously.^[@R33]^ In instances where bacterial growth data are either used to show growth curves or quantify differences in growth ability, strains were grown in 2--3 biological replicates. Fluorescence microscopy was performed on fixed *B. ovatus* cells grown to early exponential phase (*A*~600~ = 0.25--0.35) in minimal medium containing a 9:1 mixture of limit XyG oligosaccharides (XGOs) to slightly longer (average dp = 14) XGOs (see Substrates section below). These conditions circumvented the reduced growth rate of the ΔGH5 mutant on limit XGOs. Cells were fixed in formalin and stained with a polyclonal antibody raised in rabbit against purified recombinant *Bo*GH5A (Cocalico Biologicals, Reamstown, PA), following the method previously reported.^[@R34]^ The same antiserum was used to probe GH5 presence via Western blot.

Construction of a Bacteroidetes phylogeny {#S4}
-----------------------------------------

Six Bacteroidetes core genes that encode anthranilate synthase, glucose-6-phosphate isomerase, glycerol-3-phosphate dehydrogenase, DNA-directed RNA polymerase subunit beta, chorismate synthase, 3-dehydroquinate synthase and 16S rDNA were used to construct a phylogenetic tree. For each species, nucleotide sequences were concatentated in the same order, aligned using CLUSTAL-W,^[@R35]^ un- or poorly aligned basepairs were trimmed out using Gblocks,^[@R36]^ and the resulting alignment was used to construct a maximum parsimony tree with bootstraps using MEGA5.^[@R37]^

Analysis of metagenomic datasets for presence of XyGULs {#S5}
-------------------------------------------------------

Human metagenomic datasets^[@R38]--[@R41]^ were searched by BLAST for the presence of XyGUL nucleotide sequences from *B. ovatus* (27.767 kbp), *B. uniformis* (28.433 kbp for PUL1, 59.874 kbp for PUL2), *B. cellulosyliticus* (26.173 kbp) and *B. fluxus* (25.357 kbp), plus the porphyran utilisation PUL from *B. plebeius* (54.476 kbp).^[@R42]^ Each BLAST probe was first searched against the NCBI Refseq genomes database to determine the background thresholds for Blast hits to other sequenced genomes that do not contain a XyGUL using a word size of 11; this analysis failed to reveal any hits with E-values \< −20, and nucleotide identities \>90% over a length \>75 bp. Thus, in subsequent searches, we considered a metagenome to be positive for a particular XyGUL probe if it returned two or more hits ≥100bp in length with ≥90% identity and E-value ≤ −20. Because the most recent HMP metagenomic datasets assembled much larger contigs than previous studies (often aligning to over 20 continuous kbp of the respective XyGUL query), we considered hits in these datasets positive if they harbored just one hit that was ≥10 kbp with the same identity and E-value cut-offs listed above.

Germfree mouse experiments and diets {#S6}
------------------------------------

All animal experiments were approved by the University Committee on Use and Care of Animals (UCUCA) at the University of Michigan and were supervised by a veterinarian. Germfree mouse experiments were conducted in a total of 12, 6--8 week old male and female Swiss Webster mice from two litters that were born 9 days apart. Mice were randomly assigned into 3 groups of 4 animals (each was considered to be a single biological replicate) by a technician who was not familiar with the project. The investigators were not blinded to the identities of the treatment groups during the experiment. Four mice per group was chosen as the sample size based on previous studies^[@R43],[@R44]^ that used similar dietary treatment regimens and found significant alterations in competitive index using 3--7 animals per group (see [Extended Data Figure ED6](#F11){ref-type="fig"} legend for a description of statistical tests). A custom XyG-rich diet was constructed by pureeing equal amounts by wet weight of locally purchased Roma tomatoes, Romaine lettuce leaves, common eggplant with skins, and green bell peppers with seeds. This mixture was brought to a gentle simmer for 1 hour by heating in a stainless steel vessel to simulate the cooking process for these items in human foods. The mixture was cooled and combined at a ratio of 4:1 (wet weight mixture:dry weight mouse diet) with a custom polysaccharide-free rodent diet that contained sucrose as the only additional carbohydrate (Harlan Teklad, Madison, WI USA).^[@R45]^ This diet mixture was dried into biscuits and autoclaved prior to feeding to germfree mice. A different custom "polysaccharide-free diet" (Harlan Teklad TD.130343; 27% protein, 44.5% glucose, 15% fat and 8% cellulose; since *B. ovatus* cannot grow on cellulose it is assumed that this diet does not contribute usable polysaccharides) was used for longer-term feeding studies and served as the base diet for inoculating and stabilizing the input mixture of wild-type and ΔXyGUL *B. ovatus* strains. The relative ratios of competing *B. ovatus* strains were measured from total DNA extracted from freshly voided faecal pellets as previously described.^[@R43]^

Recombinant protein production {#S7}
------------------------------

### Glycoside hydrolases {#S8}

The genes of the glycoside hydrolases of this PUL were amplified by PCR using forward primers including Nde1 restriction sites and reverse primers including Xho1 restriction sites, except for GH43B, which had Sal1 restriction sites in the reverse primers ([Supplementary Table S2](#SD1){ref-type="supplementary-material"}). Constructs truncated to exclude predicted signal peptides and N-terminal lipidation sites^[@R46]^ were generated. The PCR products were digested with Nde1 and Xho1 (Nde1 and Sal1 for GH43B), and ligated into similarly digested **pET21a** vectors, followed by transformation into electrocompetent *E. coli* TOP10 cells. The cells were grown in LB overnight and plasmids were extracted using the MiniPrep kit (Qiagen) and sequenced (Eurofins MWG Operon) to identify positive clones.

Plasmids containing the PUL hydrolase genes were transformed into *E. coli* BL21 (DE3) cells by electroporation. The cells were grown at 37 °C with shaking in Terrific Broth containing 100 μM ampicillin to an OD~600~ of 0.4--0.6 when protein expression was induced by addition of 0.2 mM IPTG (isopropyl β-D-galactopyranoside) and the temperature was lowered to 25 °C. Protein expression continued for 2--3 days, after which the cells were collected by centrifugation at 4000 *g* for 10 minutes. The cells were resuspended in buffer A (20 mM sodium phosphate pH 7.4, 500 mM sodium chloride, 20 mM imidazole) and disrupted by either sonication or by passing twice through a French Press, followed by centrifugation at 27000 *g* for 45 minutes. The supernatant was loaded onto 5 ml HiTrap IMAC FF columns (GE Healthcare) using an ÄKTA FPLC (GE Healthcare) and washed thoroughly with buffer A. Each protein was purified on a separate column to eliminate the risk of cross-contamination. Tagged proteins were eluted using a linear gradient of 0--100 % buffer B (20 mM sodium phosphate pH 7.4, 500 mM sodium chloride, 500 mM imidazole) over typically 4 column volumes. Eluted proteins were concentrated using Amicon Ultra centrifugal filters (Millipore) and further purified if needed by size exclusion chromatography on a HiPrep 26/60 Sephacryl S-200 column into 50 mM sodium phosphate, pH 7.0. Liquid chromatography electrospray ionisation MS was used to verify the correct protein mass of purified proteins as described previously (data not shown).^[@R47]^ To improve the stability and solubility of certain of the enzymes, additives were included in the protein stock buffers, and these were present for all assays; *Bo*GH9A was stored in 300 mM ammonium sulphate, while *Bo*GH3A was stored in 20 % glycerol.

### Non-catalytic proteins and BoGH5A truncation variants {#S9}

Expression vector **pET21a** (Novagen) containing *Bo*GH5A (pBoGH5) was used for subsequent cloning of the BACON domain (residues 28-116), the GH5 catalytic domain (residues 117-489), and two active-site mutants, generating **pBACON**, **pCAT**, **pBoGH5-E430A** and **pCAT-E430A**, respectively. cDNA encoding the BACON and GH5 domains were amplified by PCR using forward primers including NdeI restriction sites and reverse primers including XhoI ([Supplementary Table S3](#SD1){ref-type="supplementary-material"}). Both contained a C-terminal (His)~6~ tag, and a TEV-cleavage site was added before the tag at the C-terminal end of the BACON domain insert. The catalytic nucleophile mutants of full-length *Bo*GH5A and the GH5 domain were generated using Q5^®^ high affinity DNA polymerase (New England BioLabs) from **pBoGH5** and **pCAT**. The gene fragments corresponding to amino acids 28-519 of SusD-like Bacova_02651 and 34-456 of Bacova_02650 gene products were amplified from *B. ovatus* genomic DNA by PCR using forward primers including NdeI restriction sites and reverse primers including XhoI ([Supplementary Table S3](#SD1){ref-type="supplementary-material"}). The gene products were ligated into a modified version of **pET-28a** (EMD Biosciences) containing a recombinant tobacco etch virus (rTEV) protease recognition site. Heterologous protein production in *E. coli* BL21 and purification was subsequently performed essentially as described for the glycoside hydrolases of the XyGUL; SDS-PAGE was used to confirm the purity of the proteins.

Analytical methods {#S10}
------------------

### Matrix-assisted laser desorption/ionisation-time-of-flight (MALDI-TOF) analysis of oligosaccharides {#S11}

Xylogluco-oligosaccharides (XyGOs) products were analysed by MALDI-TOF mass spectrometry on an LT3 Plus mass spectrometer (SAI Ltd., UK) operated by the MALDI Mainframe 2, Maldi Control software (version 1.03.51, SAI Ltd., UK). A matrix of 2,5-dihydroxybenzoic acid (DHB) (10 mg ml^−1^ in water) was used. The number of laser pulses was varied and the resulting individual spectra were summed to optimise signal-to-noise.

### Neutral sugar analysis by High Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD) {#S12}

Oligo- and monosaccharides were analysed on a Dionex ICS-3000 HPLC system operated by Chromeleon software version 6.80 (Dionex) using a Dionex Carbopac PA200 column. Solvent A was water, solvent B 1 M sodium hydroxide and solvent C 1 M sodium acetate. Depending on the analytes, the following gradients were employed:

-   *Gradient A:* 0 to 5 min, 10 % B, 2 % C; 5 to 12 min, 10 % B and a linear gradient from 2--30 % C; 12 to 12.1 min, 50 % B, 50 % C; 12.1 to 13 min, an exponential gradient (curve setting 9) of B and C back to initial conditions; 13 to 17 min, initial conditions.

-   *Gradient B:* 0 to 4 min, 10 % B, 6 % C; 4 to 17 min, 10 % B and a linear gradient from 0--25 % C; 17 to 17.1 min, 50 % B, 50 % C; 17.1 to 18 min, an exponential gradient (curve setting 9) of B and C back to initial conditions; 18 to 22 min, initial conditions.

-   *Gradient C:* column pre-conditioned prior to injection by −13 to −3 min, 12 % B, 6.8 % C; −3 to 0 min, 100 % A; 0 to 25 min, 100 % A.

Substrates {#S13}
----------

The 4-nitrophenyl glycoside substrates used in this study (Glc-α-PNP, Glc-β-PNP, Gal-α-PNP, Gal-β-PNP, Xyl-α-PNP, Xyl-β-PNP, L- Ara*f*-α-PNP, L-Ara*f*-β-PNP) were purchased from Sigma-Aldrich. 2-chloro-4-nitrophenyl oligosaccharide substrates GGGG-β-CNP, XXXG-β-CNP, and XLLG-β-CNP were synthesised as described previously^[@R48]^ and L-Fuc-β-CNP was purchased from Carbosynth. Xyloglucan (tamarind seed), arabinoxylan, barley mixed linkage glucan, curdlan, galactan, gluco- and galactomannan, lichenan, carboxymethyl cellulose and hydroxyethyl cellulose, XXXG, isoprimeverose, cello-oligosaccharides, and XyGOs with a higher degree of polymerization (average degree of polymerization = 14) were purchased from Megazyme.

A mixture of oligosaccharides from tamarind xyloglucan was produced by dissolving 1 g of the polysaccharide in 100 ml water at 55 °C under vigorous stirring. The temperature was lowered to 37 °C and the *endo*-xyloglucanase *Bo*GH5A (1 μM; *vide infra*) and phosphate buffer (to 50 mM, pH 7.0) was added, and the reaction proceeded overnight to completion, as assessed by HPAEC-PAD and LC-ESI-MS.^[@R49]^ The solution was passed through a Biogel-P2 column using water as eluent to remove phosphate buffer. Fractions containing XyGOs were collected, lyophilised, and analysed by HPAEC-PAD (gradient B) to determine purity. The final yield was 490 mg. XLLG was prepared from tamarind XyGO mixture as described previously.^[@R50]^ A similar mixture of XyGOs was also purchased from Megazyme.

GXXG was produced by dissolving XXXG in 50 mM citrate buffer, pH 6.0, and 0.4 μM of the α-xylosidase *Bo*GH31A (*vide infra*) to a final substrate concentration of 40 mM. The reaction was incubated at 37 °C overnight, and MALDI-TOF was used to verify that the reaction had gone to completion. The enzyme was denatured by boiling and removed by centrifugation. Further purification of the oligosaccharide was not performed, so the GXXG prepared in this way also contained an equimolar amount of xylose.

GLLG was produced by dissolving XLLG in 20 mM citrate buffer, pH 6.0, and 0.6 μM of the α-xylosidase *Bo*GH31A (*vide infra*) to a final substrate concentration of 50 mM. The reaction was incubated at 37 °C overnight, and MALDI-TOF was used to verify that the reaction had gone to completion. The enzyme was denatured by boiling and removed by centrifugation. Further purification of the oligosaccharide was not performed; therefore experiments using GLLG also contained an equimolar amount of xylose.

LLG was produced by incubating GLLG (final substrate concentration 50 mM) in 50 mM citrate buffer, pH 6.0, with 5 μM of the β-glucosidase *Bo*GH3B (*vide infra*). The reaction was incubated at 37 °C overnight, and later analysed by MALDI-TOF MS; the reaction went to approximately 50 % completion. The enzyme was denatured by boiling and removed by centrifugation. As no further purification steps were taken, the LLG prepared in this way also contains an equimolar amount of glucose, as well as a significant amount of the GLLG starting material and the monosaccharide xylose from the previous preparatory step.

### Extraction of tomato and lettuce xyloglucan and production of xyloglucan oligosaccharides {#S14}

Using a modified and scaled-up version of the protocol outlined by Hsieh and Harris,^[@R51]^ xyloglucan polysaccharide was extracted from approximately 500 g freshly purchased ripe tomato fruit or iceberg lettuce leaves, obtained from a local grocery store. Fresh plant material was homogenised in 70 % aqueous ethanol using a high-speed blender, collected by filtration on Miracloth and ground to a fine powder in liquid nitrogen. Charged polysaccharides were removed by repeated 70 % ethanol wash and filtration steps. Hemicellulosic polysaccharides were extracted in 6 M sodium hydroxide, containing 1 % sodium borohydride to prevent alkaline peeling, followed by neutralisation by addition of acetic acid. The neutralised solution was filtered and the filtrate was dialysed extensively to remove salts in deionised water. The resulting hemicellulose fractions were each incubated with 135 units of the xylanase *Cj*CBM22-GH10 (Xyn10A) and 45 units of mannanase 26A (both purchased from NZYtech) for 16 hours at 37 °C, to hydrolyse contaminating xylan and mannan, respectively. The resulting xylo- and manno-oligosaccharides were removed in subsequent ethanol washing steps. The final yield of tomato xyloglucan was 488 mg, and of lettuce xyloglucan was 560 mg.

Ethanol was added to the neutralised solution to a final concentration of 70 % to precipitate polysaccharides, followed by centrifugation at 4000 *g* for 30 minutes (or 24000 *g* for 10--15 minutes). The supernatant was discarded and the pellet washed three times with 70 % ethanol. The final pellet was dissolved in water and loaded onto a Q Sepharose column (GE Lifesciences) pre-equilibrated with 10 mM imidazole (pH 7.0). Uncharged hemicellulosic polysaccharides were washed out by addition of three column volumes of the same buffer, while charged pectins were bound to the matrix. The resulting hemicellulose containing fractions were each incubated with 150 units of the xylanase *Cj*CBM22-GH10 (Xyn10A) and 150 units of mannanase 26A (both purchased from NZYtech) for 16 hours at 37 °C, to hydrolyse contaminating xylan and mannan, respectively. The final yield of tomato xyloglucan was 170 mg, and of lettuce xyloglucan was 180 mg.

Prior to analysis by HPAEC-PAD (gradient C), the products (1 mg) were hydrolysed by incubation with 2 M trifluoroacetic acid (TFA) for 3 hours at 120 °C (1 ml total volume). Hydrolysis products were vacuum dried and resuspended in deionised water, then filtered (0.2 μm filter). The tomato xyloglucan comprised Glc, Xyl, Gal and Ara. The lettuce xyloglucan comprised Glc, Xyl, Gal and Fuc. Both materials were found to also contain GalA and Rha, at levels indicating pectin contamination of up to 50 %. An anion exchange method adapted from Hoffman *et al.*^[@R52]^ was used to remove pectins. Dry material (84 mg lettuce xyloglucan and 63 mg tomato XyG) was redissolved in 10 mM imidazole-HCl buffer, pH 7.0. This solution was mixed thoroughly with Q-sepharose fast-flow resin (Sigma-Aldrich), to which anionic pectic polysaccharides and any proteins bound. The flow-through, containing neutral polysaccharides (xyloglucans and any trace remaining amounts of mannans and xylans), was collected by applying to a vacuum. Neutral sugar analysis showed a marked decrease in pectin contamination, to around 5 %.

One hundred mg of crude xyloglucan polysaccharide obtained from tomato or lettuce was dissolved in water (20 ml) and incubated with 0.2 μM of the *Bo*GH5A in 50 mM phosphate buffer (pH 7.0) at 37 °C overnight. Ethanol was added to a final concentration of 70 % to precipitate remaining polysaccharides, and the soluble oligosaccharide products were recovered by filtration and lyophilisation of the filtrate. The XyGOs were analysed by HPAEC-PAD (gradient B) and MALDI-TOF. The final yield was 64 mg from the tomato xyloglucan and 58 mg from the lettuce XyG.

Enzyme assays {#S15}
-------------

All assays were carried out at 37 °C, at or near the buffer (50 mM) and pH optima of the individual enzyme, unless otherwise stated. Curve fitting was performed using Origin 8 (OriginLab). For all quantitative enzyme assays at least two technical replicates were performed at each assay condition (e.g., pH value, substrate concentration, etc.).

### pH dependence studies {#S16}

pH optima for each enzyme were determined, where possible, using the PNP-Gly assay, described below, except for *Bo*GH5A for which it was determined using tamarind xyloglucan as substrate and the bicinchoninic acid (BCA) reducing sugar assay.^[@R53],[@R54]^ The buffers used are shown in Source Data [Figures S1--S6](#SD1){ref-type="supplementary-material"}. The concentrations of enzyme used were typically in the range 0.2 -- 2 μM, unless otherwise stated.

### PNP- and CNP-glycoside assays {#S17}

Assays in which PNP-glycosides were used as substrates were monitored for the release of 4-nitrophenolate using *A*~410~, on a Cary 50 spectrophotometer. For discontinuous assays, samples were added to an equal volume of 200 mM Na~2~CO~3~ to terminate the reactions by raising the pH to 11.0. An extinction coefficient of 18500 M^−1^ cm^−1^ was used to calculate product concentration from absorbance values.^[@R55]^ For some very slow reactions, a continuous assay was used in a Cary 300 spectrophotometer; an extinction coefficient of 10500 M^−1^ cm^−1^ (pH 7.0) was used for these assays.^[@R56]^

Assays utilising CNP-glycosides were monitored continuously for the release of 2-chloro-4-nitrophenolate using a Cary 300 spectrophotometer (Agilent Technologies). An extinction coefficient of 12936 M^−1^ cm^−1^, determined from a standard curve, was used to calculate product concentration from *A*~405~ values.

### Reducing sugar assays {#S18}

Hydrolysis of polysaccharide substrates was measured by an increase in reducing sugars, using the 3,5-dinitrosalicylic acid reducing sugar assay (DNSA)^[@R57]^ *versus* a standard curve of Glc (1--6 mM). Reaction samples were added to an equal volume of DNSA reagent to terminate the reaction, and the colour was developed by boiling for 20 minutes, prior to measuring *A*~575~ on a Cary 50 spectrophotometer (Agilent Technologies).

### Assays for the detection of specific monosaccharide release {#S19}

A linked galactose dehydrogenase/galactose mutarotase assay (Megazyme) was used to quantify the release of galactose or arabinose from xyloglucan or XyGOs. The release of galactose or arabinose led to the stoichiometric reduction of NAD^+^ to NADH, giving an increase in *A*~340~ (ε 6230 M^−1^ cm^−1^ at pH 7.0),^[@R56]^ which was read continuously using a Cary 300 spectrophotometer.

A second linked assay (Glucose/Mannose/Fructose detection kit, Megazyme) was used to quantify the release of glucose monosaccharides. The protocol provided in the manufacturer's instructions was modified for use as a continuous assay. The release of a glucose monosaccharide corresponds stoichiometrically with the reduction of a molecule of NADP^+^ to NADPH, which leads to an increase in *A*~340~ (ε 6220 M^−1^ cm^−1^),^[@R56]^ observed continuously using a Cary 300 spectrophotometer. Reactions were carried out in the triethylamine buffer (pH 7.6) provided with the assay kit.

### Assays using HPAEC-PAD analysis {#S20}

Enzymatic reactions on xylogluco- and cello-oligosaccharides were performed in 50 μl of 50 mM buffer and were stopped by addition of 2 μl of 5 M sodium hydroxide prior to HPAEC-PAD analysis. Gradient A was used for reactions with XXXG or XLLG and Gradient B was used for assays against xyloglucan polysaccharides and cello-oligosaccharides.

Affinity gel electrophoresis {#S21}
----------------------------

Affinity gel electrophoresis was performed for 90 min at room temperature on non-denaturing 10% (w/v) polyacrylamide gels, essentially as previously described.^[@R58]^

Isothermal titration calorimetry (ITC) {#S22}
--------------------------------------

Isothermal titration calorimetry (ITC) was performed essentially as previously described^[@R59],[@R60]^ using a MicroCal VP-ITC calorimeter. Proteins were dialysed into 20 mM HEPES 100 mM NaCl pH 7.0 and polysaccharides were dissolved in the dialysis buffer separately. The proteins (20--40 μM) were placed in the sample cell, and after the temperature equilibrated to 25°C, a first injection of 2 μL was performed followed by 25 subsequent injections of 10 μL of either polysaccharide (1--2.5 mg/mL). The solution was stirred at 280 rpm and the resulting heat of reaction was recorded. Data were analysed using the Origin software program.

Structural biology {#S23}
------------------

### BoGH5A Preparation for Crystallisation {#S24}

Typically \~ 5 g of cell paste were resuspended in 5x volumes of Buffer C (50 mM HEPES pH 7.0, 0.5 M NaCl, 30 mM imidazole) and cells were lysed using three 15 s pulses of sonication at maximum amplitude using an MSE Soniprep 150 sonicator. Cell debris was removed by centrifugation at 38000 *g* for 30 minutes at 4°C. The supernatant was applied to a 5 ml GE Healthcare HiTrap Nickel NTA column that had been equilibrated in Buffer C at 10°C using an Äkta Xpress purification system. The column was washed with 5 column volumes of Buffer C before a 100 ml gradient of Buffer D (Buffer C + 300 mM imidazole) was applied to elute the protein. Fractions of 1.6 ml were collected along the gradient. Peak fractions containing the enzyme were pooled and concentrated using a 30 kDa molecular weight cut off Sartorius concentrator by centrifugation at 5 *g* to a volume of approximately 1 ml. The protein was then applied to a GE Healthcare 16/60 HiLoad Superdex 200 column, which had been equilibrated with gel filtration buffer (10 mM Tris pH 8.0, 250 mM NaCl). Following a void volume of 45 ml, 1.6 ml fractions were collected. Fractions containing *Bo*GH5A were combined and buffer exchanged into 10 mM Tris pH 8.0, 50 mM NaCl before final concentration to 53 mg ml^−1^ as judged by absorption at 280 nm using an extinction coefficient of 79300 M^−1^ cm^−1^ and a molecular weight of 51674 Da.

To prepare the protein:XyGO complex 53 mg ml^−1^ *Bo*GH5A was mixed with 100 mM XyGO (10 % XLXG, 90 % XXLG) to give final concentrations of 48 mg ml^−1^ protein and 10 mM XyGO.

### Structure solution and refinement {#S25}

Crystallisation trials were set up in sitting drops using a Mosquito robot (TTP Labtech). Diffraction-quality crystals were obtained in 0.1 M Bis-Tris pH 6.5, 20 % w/v polyethylene glycol monomethyl ether 5,000. Crystals were cryo-protected by soaking in mother liquor supplemented with 20 % (v/v) ethylene glycol for 30 seconds prior to flash freezing in liquid N~2~.

X-ray diffraction data were collected at the Diamond Synchrotron; station I03. Data were processed using XDS.^[@R61]^ The structure was determined by molecular replacement in PHASER^[@R62]^ using chain A of the *Paenibacillus pabuli* GH5 (PDB ID 2jep) as the search model. Two molecules were located in the asymmetric unit with log-likelihood gains of 99 and 364 for the first and second molecules respectively. The crucial step in model building was to harness 3 cycles of phase improvement, including NCS averaging, in PARROT^[@R63]^, prior to model construction using ARPwARP^[@R64]^. Subsequent model building and refinement was performed using REFMAC5^[@R65]^ and COOT^[@R66]^, respectively, with the validity of the model monitored using MolProbity^[@R67]^ prior to deposition (PDB ID 3zmr).

Extended Data {#S26}
=============

![Evolution of the genomic region containing the XyGUL and corresponding growth on XyG as a sole carbon source. a. Genomic organisation of 11 representative strains from 3 different species of *Bacteroides*. b. Growth of these strains on tamarind XyG with glucose and xylose as controls (average of n=2 growths per strain). The observation that one *B. ovatus* strain (SD CMC 3f) lacks a corresponding XyGUL, as do all *B. xylanisolvens* (the closest cultured relative of *B. ovatus*), suggests that the XyGUL entered *B. ovatus* after it diverged. Also note that two other unrelated flanking PULs show variable presence at this locus, suggesting that it is a 'hotspot' for PUL evolution.](nihms543896f6){#F6}

![Activation of putative XyGULs in Bacteroidetes isolates via growth on XyG. a. Sentinel (ref. [@R7]) *susC*-like gene expression (n=3, expression measurements from separately grown cultures relative to a minimal medium plus glucose control). b. Growth profiles of the corresponding strains in medium containing tamarind XyG with glucose and xylose as controls (average of n=2 growths per strain). Error bars represent standard errors of the mean.](nihms543896f7){#F7}

![Cell-surface localisation of *Bo*GH5A and effect of localisation on *B. ovatus* growth. a. staining of fixed wild-type and mutant *B. ovatus* strains. b. Western blot indicating that *Bo*GH5A is still produced in the C1A lipidation site mutant, albeit in multiple degraded forms. c. Growth of wild-type (positive control), Δ*Bo*GH5A (negative control) and *Bo*GH5A-C1A strains on tamarind XyG. The *Bo*GH5A-C1A mutant exhibits \~2.6-fold slower exponential growth than the wild-type. Vertical error bars on each curve indicate the standard deviation of the mean (n=3 replicates). The residual growth ability of the *Bo*GH5A-C1A strain, despite mis-localization, is unlikely to be explained by the presence of *Bo*GH5A enzyme accumulation in the supernatant, which was only detected by Western blot for wild-type bacteria expressing *Bo*GH5A on the cell surface. Detection of *Bo*GH5A in panels a and b was achieved with a rabbit polyclonal antibody raised against the recombinant protein produced in *E. coli*. Panels a nd b show representative data two experiments each that yielded very similar results.](nihms543896f8){#F8}

![Non-catalytic interaction of *Bo*GH5A variants, SusD-like Bacova_02651 and Bacova_02650 of the XyGUL with polysaccharides. a. SDS-PAGE of recombinant proteins (representative data from at least three preparations for each protein is shown). b. Affinity gel electrophoresis (representative data from at least two gels for each experimental condition). c. Isothermal titration calorimetry (ITC); the upper graph in each pair shows the raw heat during titration, while the lower graph shows the integrated heats after correction. d. Association constants and thermodynamic parameters obtained from ITC data. Bovine serum albumin (BSA) was used as non-interacting negative control protein. Other protein names were abbreviated as follows: BACON, residues Cys1-Tyr97 corresponding to the BACON domain of *Bo*GH5A; Bacova_02651, SusD-like XyGUL gene product; Bacova_02650, SusE-positioned XyGUL gene product; *Bo*GH5A E430A, full-length (Cys1 to Asn470) catalytic nucleophile mutant of *Bo*GH5A; CAT E430A, catalytic nucleophile mutant of the *Bo*GH5A catalytic domain only (Ser98 to Asn470). Reducing-sugar assays confirmed the catalytic mutants had no detectable hydrolytic activity on xyloglucan (data not shown), while an active variant (i.e., E430) of CAT had a 2-fold higher specific activity than the full-length, wild-type *Bo*GH5A at saturating xyloglucan concentrations (0.5 -- 3 mM).](nihms543896f9){#F9}

![Abundance of *Bacteroides* XyGULs in human from a survey of metagenomic sequencing data from a total of 250 adult human samples (211 healthy, 27 ulcerative colitis, 12 Crohn's Disease; see Methods for references). Datasets were individually queried by BLAST using the entire XyGUL nucleotide sequence from each of the four *Bacteroides* species listed at the top (*cf.* [Fig. 2](#F2){ref-type="fig"}) and a PUL involved in degrading the red algal polysaccharide porphyran. Each horizontal line represents the presence or absence of a hit in a single individual. The leftmost column summarizes the total XyGUL content in each person (annotated according to the color key in the upper right corner). The XyGUL frequency across all 250 samples is shown at the bottom for each condition. The graph at the far right illustrates the variation in sequencing depth for each sample/study: black lines show the average depth in megabasepairs (Mbp) for each study; the light gray line shows the depth for each individual sample.](nihms543896f10){#F10}

![Presence of the XyGUL confers a fitness advantage to *B. ovatus* in the presence of dietary xyloglucan, but only when other dietary polysaccharides are eliminated. a. MALDI analysis of *Bo*GH5A-digested alkaline extract from a custom mouse diet that contained a large amount of xyloglucan from natural vegetable sources (equal amounts of cooked bell pepper, eggplant, tomato fruit and lettuce; see Methods), indicating the presence of both solanaceous (arabinogalacto)xyloglucan and (fucogalacto)xyloglucan. b. qPCR analysis of XyGUL sentinel gene (ref. [@R7]) expression in wild-type *B. ovatus* grown on extracted polysaccharides from the XyG-rich custom diet, demonstrating that it significantly activates XyGUL expression over a glucose control (error bars show the standard deviation of the mean of three biological replicates for both growth conditions). c. *In vitro* growth of wild-type and ΔXyGUL *B. ovatus* strains in the polysaccharide extract from the XyG-rich diet, including glucose and tamarind XyG as positive and negative control substrates, respectively. Compared to growth on tamarind XyG (middle panel), the incomplete growth defect of ΔXyGUL mutant on the food extract (right panel) indicates that the food contains other polysaccharides that are accessible by *B. ovatus*. Vertical error bars on each curve indicate the standard deviation of the mean of 3 replicates. d. *In vivo* competition of wild-type and ΔXyGUL *B. ovatus* strains in mice consuming various amounts of dietary XyG. All mice were initially fed a synthetic diet containing glucose as the sole digestible carbohydrate for 1 week and then gavaged with a 7:3 ratio of ΔXyGUL:WT (based on independent culture optical densities, total of \~10^8^ viable *B. ovatus*) and the communities were allowed to equilibrate for 3 days. Despite the initial ratio biased in favour of the ΔXyGUL strain, the communities equilibrated in the range 5:5 -- 4:6, but thereafter remained stable while mice were maintained on the XyG-free diet (blue boxes in three competition plots). Subsequent to community stabilization, three different dietary regimens were analysed. Left panel: Mice were maintained on the control diet (glucose only, devoid of XyG) between days 5--37, but switched to water containing 0.25% purified XyG for days 15--37 (gray box); Middle panel: Mice were switched to a xyloglucan-rich, custom diet from natural food sources while simultaneously drinking water containing 0.25% purified XyG (green box). These mice were then switched to the glucose-only, XyG-free control diet while remaining on water containing 0.25% XyG (gray box); Right panel: Mice were switched to the XyG-rich diet between days 3--15 but given normal water (yellow box), these mice were not continued further on any dietary regimen. Maintenance on either XyG food/XyG water (middle panel) or XyG food only (right panel) does not exert a measurable fitness pressure on the competing WT and ΔXyGUL strains. However, when the complex natural food polysaccharides were withheld while 0.25% XyG was maintained in water, a clear fitness pressure was observed via the significant, sequential reduction of the ΔXyGUL mutant between 15--37 days. These data suggest that although the XyGUL confers an advantage to *B. ovatus* by broadening its substrate range to include XyG, the presence of alternative oligo- and polysaccharides (e.g., other hemicelluloses, pectins) in a complex vegetable-based diet is nonetheless sufficient to support strains lacking this locus *in vivo*. Each data point is the mean abundance of the indicated strain in 4 separate mice and error bars represent one standard deviation. Measurements conformed to a normal distribution based on the observation that 67% of all assay values were within one standard deviation of their respective means. Asterisks indicate statistically significant alterations (p \< 0.01; student's *t* test, one-tailed, paired) in strain abundance relative to the day 15 samples, which immediately preceded the diet switch aimed at isolating XyG as the sole exogenous polysaccharide.](nihms543896f11){#F11}

###### 

Summary of kinetic analyses of XyGUL glycoside hydrolases.[\*](#TFN1){ref-type="table-fn"}

  Enzyme           Substrate ^b^                         *k*~cat~ (s^−1^)[†](#TFN2){ref-type="table-fn"}   *K*~m~ (mM)[‡](#TFN3){ref-type="table-fn"}   *k*~cat~/*K*~m~ (s^−1^ mM^−1^)[‡](#TFN3){ref-type="table-fn"},[§](#TFN4){ref-type="table-fn"}   Assay^\|\|^
  ---------------- ------------------------------------- ------------------------------------------------- -------------------------------------------- ----------------------------------------------------------------------------------------------- -------------
  *Bo*GH2A         Gal-β-PNP                             4.0 ± 0.092                                       0.087 ± 0.0074                               46.0                                                                                            PNP
                                                                                                                                                                                                                                                        
  *Bo*GH3A         Glc-β-PNP                             Trace activity                                                                                                                                                                                 PNP
  cellobiose       Trace activity                                                                                                                       Glc-kit                                                                                         
  cellotetraose    65.0 ± 3.81                           2.49 ± 0.42                                       21.3                                         Glc-kit                                                                                         
  cellohexaose     0.62 ± 0.15                           0.698 ± 0.52                                      0.90                                         Glc-kit                                                                                         
  GLLG             n.d.[¶](#TFN5){ref-type="table-fn"}   n.d.                                              0.15                                         Glc-kit                                                                                         
  GXXG             n.d.                                  n.d.                                              3.41                                         Glc-kit                                                                                         
                                                                                                                                                                                                                                                        
  *Bo*GH3B         Glc-β-PNP                             1.74 ± 0.21                                       0.155 ± 0.039                                11.2                                                                                            PNP
  Gal-β-PNP        Trace activity                                                                                                                       PNP                                                                                             
  cellobiose       1.57 ± 0.11                           0.68 ± 0.16                                       2.3                                          Glc-kit                                                                                         
  cellotetraose    3.99 ± 0.31                           0.23 ± 0.060                                      17.3                                         Glc-kit                                                                                         
  cellohexaose     4.91 ± 0.71                           0.47 ± 0.21                                       10.4                                         Glc-kit                                                                                         
  GLLG             n.d.                                  n.d.                                              0.18                                         Glc-kit                                                                                         
  GXXG             n.d.                                  n.d.                                              3.34                                         Glc-kit                                                                                         
                                                                                                                                                                                                                                                        
  *Bo*GH5A         XXXG-β-CNP                            10.5 ± 0.14                                       0.036 ± 0.0027                               291.7                                                                                           CNP
  XLLG-β-CNP       11.1 ± 1.13                           0.145 ± 0.024                                     76.5                                         CNP                                                                                             
  GGGG-β-CNP       0.12 ± 0.025                          3.59 ± 1.27                                       0.034                                        CNP                                                                                             
  Tamarind XyG     435.3 ± 25.6                          0.82 ± 0.17 mg ml^−1^                             534.0 s^−1^ mg^−1^ ml                        DNSA                                                                                            
  Lettuce XyG      n.d.                                  n.d.                                              543.1 s^−1^ mg^−1^ ml                        DNSA                                                                                            
  Tomato XyG       n.d.                                  n.d.                                              501.5 s^−1^ mg^−1^ ml                        DNSA                                                                                            
                                                                                                                                                                                                                                                        
  *Bo*GH9A         Tomato XG                             Active (MALDI-MS data)                                                                                                                                                                         DNSA
                                                                                                                                                                                                                                                        
  *Bo*GH31A        Xyl-α-PNP                             1.60 ± 0.031                                      7.7 ± 0.273                                  0.21                                                                                            PNP
  Glc-α-PNP        0.071 ± 0.015                         31.8 ± 5.1                                        0.0022                                       PNP                                                                                             
  XXXG             32.6 ± 2.1                            0.223 ± 0.046                                     146.2                                        HPLC                                                                                            
  XLLG             31.0 ± 1.9                            0.378 ± 0.075                                     82.0                                         HPLC                                                                                            
  Isoprimeverose   1.78 ± 0.21                           38.1 ± 7.1                                        0.047                                        Glc-kit                                                                                         
                                                                                                                                                                                                                                                        
  *Bo*GH43A        L-Ara*f*-α-PNP                        0.057 ± 0.001                                     0.71 ± 0.03                                  0.081                                                                                           PNP
  Xyl-β-PNP        0.26 ± 0.005                          6.58 ± 0.21                                       0.039                                        PNP                                                                                             
  Tomato XyGOs     n.d.                                  n.d.                                              0.013 s^−1^ mg^−1^ ml                        GDh-kit                                                                                         
  Tomato XyG       Active                                                                                                                               GDh-kit                                                                                         
                                                                                                                                                                                                                                                        
  *Bo*GH43B        L-Ara*f*-α-PNP                        5.0 × 10^−4^ ± 8.1 × 10^−5^                       6.6 ± 2.3                                    7.6 × 10^−5^                                                                                    Cont. assay
  Tomato XyGOs     n.d.                                  n.d.                                              0.0024 s^−1^ mg^−1^ ml                       GDh-kit                                                                                         
  Tomato XyG       Active                                                                                                                               GDh-kit                                                                                         

pH-rate profiles, full kinetic data plots, and carbohydrate product analyses are available in [Supplementary Figures S1--S20](#SD1){ref-type="supplementary-material"} for all enzymes.

Data is only given for those substrates on which a given enzyme was active. For example, *Bo*GH5A and *Bo*GH9A were not active on arabinoxylan, barley mixed-linkage glucan, curdlan, galactan, gluco- and galactomannan, lichenan, carboxymethyl cellulose, or hydroxyethyl cellulose. The full panel of chromogenic and natural substrates against which enzymes were tested is described in the Methods ([Supplementary Information](#SD1){ref-type="supplementary-material"}).

These units apply to all values in the column, unless otherwise stated. Standard errors of means are indicated.

For substrates for which individual *k*~cat~ and *K*~m~ values are not reported, *k*~cat~/*K*~m~ values were obtained from linear curve fitting to initial rate data in the \[S\] ≪ *K*~m(apparent)~ regime, where the standard Michaelis-Menten equation reduces to *v*~o~ = *k*~cat~\[E\]\[S\]/*K*~m~

n.d.: not determined.

###### 

Growth of mutant *B. ovatus* strains on xyloglucan relative to wild-type *B. ovatus* 8384.

  Strain                                                                       Relative Growth[\*](#TFN6){ref-type="table-fn"} (%)   Relative Rate (ΔA~600~/Δtime)                Relative Lag (Δtime~Mutant~/Δtime~WT~)
  ---------------------------------- ----------------------------------------- ----------------------------------------------------- -------------------------------------------- ------------------------------------------
  ΔGH5                               tamarind xyloglucan                       No Growth                                                                                          
  dp14 tamarind xyloglucan           139 ± 17[†](#TFN7){ref-type="table-fn"}   2.2 ± 0.2[†](#TFN7){ref-type="table-fn"}              1.2 ± 0.1                                    
  GH5-digested tamarind xyloglucan   70 ± 9                                    0.6 ± 0.2[‡](#TFN8){ref-type="table-fn"}              1.2 ± 0.2                                    
  XGOs (Megazyme)                    71 ± 6[‡](#TFN8){ref-type="table-fn"}     0.6 ± 0.1[†](#TFN7){ref-type="table-fn"}              1.3 ± 0.3                                    
                                                                                                                                                                                  
  ΔGH9                               tamarind xyloglucan                       119 ± 11                                              1.2 ± 0.2                                    1.0 ± 0.1
  dp14 tamarind xyloglucan           114 ± 18                                  0.9 ± 0.1                                             1.1 ± 0.1                                    
  GH5-digested tamarind xyloglucan   105 ± 6                                   1.0 ± 0.1                                             1.3 ± 0.3                                    
  XGOs (Megazyme)                    95 ± 13                                   0.9 ± 0.1                                             1.2 ± 0.2                                    
                                                                                                                                                                                  
  ΔGH31                              tamarind xyloglucan                       18 ± 2[†](#TFN7){ref-type="table-fn"}                 0.06 ± 0.05[†](#TFN7){ref-type="table-fn"}   3.3 ± 0.8[†](#TFN7){ref-type="table-fn"}
  dp14 tamarind xyloglucan           No Growth                                                                                                                                    
  GH5-digested tamarind xyloglucan   No Growth                                                                                                                                    
  XGOs (Megazyme)                    No Growth                                                                                                                                    

Growth conditions are described in Methods. Relative growth values are average percent of wild-type *B. ovatus* 8384 growth density. No growth was defined as an increase of OD~600~ \< 0.05, measured from the initial baseline to the maximum achieved. Standard errors of mean values for three biological replicates are indicated.

*p* value ≤0.05 as determined by unpaired t-test

*p* value = 0.05--0.1 as determined by unpaired t-test

###### 

Data collection and refinement statistics for *Bo*GH5A:XXXG complex.

                                *Bo*GH5A:XXXG (PDB ID 3zmr)
  ----------------------------- -------------------------------------------------------------
  **Data collection**           
  Space group                   P2~1~
  Cell dimensions               
   *a*, *b*, *c* (Å)            46.8, 147.2, 84.1
   α, β, γ (°)                  90.0, 92.8, 90.0
  Resolution (Å)                72.99 - 1.43 (1.47 -- 1.43)[\*](#TFN9){ref-type="table-fn"}
  *R*~merqe~                    0.058 (0.575)
  *I*/σ*I*                      12.2 (2.2)
  Completeness (%)              99.5 (99.8)
  Redundancy                    2.1 (2.0)
  **Refinement**                
  Resolution (Å)                72.99 - 1.43
  No. reflections (Work/Free)   197432/10458
  *R*~work~/*R*~free~           0.12/0.16
  No. atoms                     
   Protein                      7403
   Ligand/ion                   226
   Water                        1342
  Avg *B*-factors               
   Protein                      19
   Ligand/ion                   38
   Water                        32
  R.m.s. deviations             
   Bond lengths (Å)             0.011
   Bond angles (°)              1.46

Values in parentheses are for highest-resolution shell.
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![Representative structures of XXXG- and XXGG-type xyloglucans. a. XXXG-type xyloglucans, comprised of a Glc~4~Xyl~3~ repeating motif with variable branch extensions (bold residues). Tamarind seed xyloglucan and primary cell wall xyloglucans (e.g. from lettuce leaves) are distinguished by the absence of fucose in the former. b. XXGG-type xyloglucans, comprised of Glc~4~Xyl~2~ repeating motif. These xyloglucans are common to solanaceous species (e.g. tomato) and are typified by branches extended with arabinofuranosyl residues. Standard single-letter abbreviations^[@R5]^ for designating backbone decorations are shown.](nihms543896f1){#F1}

![Structure of the *B. ovatus* xyloglucan utilization locus and evolution in the Bacteroidetes lineage. a. PULs with partial homology and synteny; homologous genes are connected by gray bars and flanking genes lacking synteny are shown as semi-transparent. b. PULs with partial homology, but lacking overall synteny. [Extended Data Figure ED2](#F7){ref-type="fig"} provides transcriptional evidence that each of these gene clusters is responsive to growth on XyG.](nihms543896f2){#F2}

![The concerted action of XyGUL gene products in the degradation of xyloglucans. Most probable sequential pathways for the hydrolysis of (galacto)xyloglucan (a) and (arabinogalacto)xyloglucans (b) based on enzyme kinetic data, product analysis, and selected gene knock-out studies (see [Fig. 1](#F1){ref-type="fig"} for XyG motif abbreviations). Enzymes are represented as circles, colour-coded as in panel c: Rainbow, *endo*-xyloglucanase *Bo*GH5A; tan, *endo*-xyloglucanase *Bo*GH9A; orange, α-xylosidase *Bo*GH31A; turquoise α-L-arabinofuranosides *Bo*GH43A and/or *Bo*GH43B; yellow β-galactosidase *Bo*GH2; dark blue β-glucosidases *Bo*GH3A and/or *Bo*GH3B. c. Model of enzyme localisation by analogy with the archetypal Sus locus^[@R4]^ and based on inference of N-terminal lipoprotein modification from protein sequence data.](nihms543896f3){#F3}

![Structural biology of *Bo*GH5A. a. Tertiary structure; the two conformations observed *in crystallo* have been oriented relative to the N-terminal, membrane-anchored BACON domain (see also [Supplementary Video V1](#SD4){ref-type="supplementary-material"}). b. Wall-eyed stereo view of the binding of XXXG in the -4 to -1 subsites (see also [Supplementary Video V2](#SD5){ref-type="supplementary-material"}). The wireframe represents an unbiased 2Fo-Fc map (contoured at 0.3 electrons per Å^3^) obtained using phases calculated from the best model prior to the incorporation of any ligand in refinement.](nihms543896f4){#F4}

![Growth of different human gut-resident Bacteroidetes on xyloglucan. Each point represents the normalized maximum growth OD~600~ achieved by each strain after 4 d of growth in minimal medium with tamarind XG as the sole carbon source (average of n=2 independent growth analyses per strain). The inset shows a phylogenetic tree constructed from fully sequenced strains of the species shown; those labeled in red have the ability to grow on xyloglucan as sole carbon source and those labeled in green have PULs similar to *B. ovatus* XyGUL but were not tested for growth on XG. Bootstrap values based on 1000 replicate trees are indicated.](nihms543896f5){#F5}
